# Phase 2 Study of KH001 in Long-term Relief From Dentin Hypersensitivity

> **NCT06464939** · PHASE2 · COMPLETED · sponsor: **HysensBio Co., Ltd** · enrollment: 120 (actual)

## Conditions studied

- Dentin Hypersensitivity

## Interventions

- **DRUG:** KH001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06464939
- **Lead sponsor:** HysensBio Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-08
- **Primary completion:** 2025-12-22
- **Final completion:** 2025-12-22
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2026-01-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06464939

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06464939, "Phase 2 Study of KH001 in Long-term Relief From Dentin Hypersensitivity". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT06464939. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*